Much has been written about the demise of the traditional pharmaceutical sales model and the “Complex Buying Environment” that now pervades within our industry. The reasons have been well docu ...

This marks the fourth acquisition for Relevate, which plans to leverage games to round out its omnichannel life sciences ...

BioMarin Pharmaceutical Inc.'s stagnant shares present a compelling investment opportunity amid uncertainty in the ...

While pharmaceutical sales in many mature markets are showing stagnant growth or even regressions, the sales estimates in the emerging markets point to continued growth. In fact, it is estimated ...

In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

Mankind Pharma's strategic partnership with Bharat Serums and Vaccines poised for significant growth potential.

A first-of-its-kind analysis conducted as part of an investigation by journalists in eight countries found that some of the ...

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the ...

Tactics used to persuade U.S. doctors that potent painkillers could be safely prescribed have been used abroad, an ...

Emcure Pharma stock price is up more than 19% from its listing price and over 56% from its IPO price. The pharma stock has ...